Bausch + Lomb IPO Subscribed at a Lower Than Marketed
Price, Raising $630 Million
https://businessupside.com/2022/05/06/bausch-lomb-ipo-subscribed-at-a-lower-
than-marketed-price-raising-630-million/
Canada’s eye health care company Bausch + Lomb Corp. has priced its
IPO below the marketed range to raise $630 million, dimming hopes of
the market rebounding in the biggest listing in the U.S. in almost four
months.
In what is seen as a test of whether a profitable and stable business
can help to break the ice for dozens of start-ups who are considering
IPOs, Bausch + Lomb is one out of two businesses that have been spun
out from Bausch Health Cos and going ahead with the IPO despite the
Dow Jones industrial index witnessing the biggest drop since 2020.
Thank
you!
https://businessupside.com/